Does OCRELIZUMAB Cause Decreased appetite? 339 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 339 reports of Decreased appetite have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.6% of all adverse event reports for OCRELIZUMAB.
339
Reports of Decreased appetite with OCRELIZUMAB
0.6%
of all OCRELIZUMAB reports
6
Deaths
112
Hospitalizations
How Dangerous Is Decreased appetite From OCRELIZUMAB?
Of the 339 reports, 6 (1.8%) resulted in death, 112 (33.0%) required hospitalization, and 5 (1.5%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 339 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which OCRELIZUMAB Alternatives Have Lower Decreased appetite Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE